Sign Up to like & get
recommendations!
0
Published in 2021 at "Drug discovery today"
DOI: 10.1016/j.drudis.2021.08.009
Abstract: Biological drugs or biopharmaceuticals off patent open a large market for biosimilars and biobetters, follow-on biologics. Biobetters, in particular, are new drugs designed from existing ones with improved properties such as higher selectivity, stability, half-life…
read more here.
Keywords:
building better;
industrial application;
fundamentals industrial;
biobetters fundamentals ... See more keywords